본문바로가기
Q
U
I
C
K

Leading Innovative Vaccine/Bio Technology SK bioscience

From Prevention To Cure
mouse scroll icon SCROLL DOWN

What’s New

  • SK bioscience News CEPI funds reaches up to $210.1 mil...

    sk’s covid-19 vaccine ‘gbp510’ secures up to $173.4 million of additional funding to phase 3 clinica...

    More
  • News SK bioscience´s COVID-19...

    manufacturing facility obtains gmp certification f...

    More
  • News sk bioscience lists on kospi

    sk bioscience ceo ahn jae-yong and other officials...

    More
  • News sk bioscience and cepi expand ...

    cepi grants up to $14.2 million of funding to supp...

    More
  • News SK Bioscience - Novavax ? KDCA...

    SK Bioscience obtained exclusive rights to manufac...

    More

Investor Relations

0 PRESENT PRICE (WON)

0WON

0.00%

Our Products

PRODUCTS SKY Cellflu prefilled syringe

The first flu vaccine developed by using the cell-culturing method in Korea. It can provide a large amount of vaccine in a short period of time, as this method can produce a large amount of specific cells which are necessary for cultivating viruses in advance. Furthermore, people with egg allergies can be inoculated at the same time.

SKY Cellflu prefilled syringe image
  • SKY Cellflu prefilled syringe
  • SKY Cellflu Quadrivalent prefilled syringe
  • SKY Zoster Inj.
  • SKY Varicella Inj.